Use of cyclosporins for treatment of cerebral ischemia and brain and spinal cord injury

Details for Australian Patent Application No. 2005230400 (hide)

Owner Novartis AG

Inventors Waldmeier, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2005230400

PCT Pub. Number WO2005/097164

Priority 60/560,465 08.04.04 US

Filing date 7 April 2005

Wipo publication date 20 October 2005

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097164 Priority application(s): WO2005/097164

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230401-Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides

2005230399-Protein kinase C inhibitors for the treatment of autoimmune diseases and of transplant rejection